Cefaclor is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, Staphylococci, and Streptococcus pyogenes
- Lower respiratory tract infections including pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae, and Streptococcus (author’s comment: not a first-line agent)
- Pharyngitis and tonsillitis caused by Streptococcus pyogenes (PCN is the drug of choice).
- Pyelonephritis and cystitis caused by Escherichia coli, Proteus mirabilis, Klebsiella spp., and coagulase-negative staphylococci (author’s comment: not a first-line agent)
- Skin and skin structure infections caused by Staphylococcus aureus (MSSA) and Streptococcus pyogenes
NON-FDA APPROVED USES
NON-FDA APPROVED USES
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: July 8, 2018
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cefaclor
ID - 540084
A1 - Avdic,Edina,Pharm.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2018/07/08/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540084/all/Cefaclor
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -